Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia

BACKGROUND: Interstitial pneumonia (IP) is a disease with a poor prognosis. In addition, IP patients are more likely to develop lung cancer. Since IP patients frequently develop toxicities during cancer treatment, minimally invasive cancer treatment is warranted for such patients to maintain their q...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Shingo, Iwata, Hiromitsu, Hattori, Yukiko, Nakajima, Koichiro, Nomura, Kento, Hayashi, Kensuke, Toshito, Toshiyuki, Yamamori, Eiko, Akita, Kenji, Mizoe, Jun-etsu, Ogino, Hiroyuki, Shibamoto, Yuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935826/
https://www.ncbi.nlm.nih.gov/pubmed/35313905
http://dx.doi.org/10.1186/s13014-022-02027-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935826/
https://www.ncbi.nlm.nih.gov/pubmed/35313905
http://dx.doi.org/10.1186/s13014-022-02027-0

Ejemplares similares